Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT.
Male patients with a qualifying encounter in the measurement period AND with a diagnosis of prostate cancer AND with an order for ADT or an active medication of ADT with an intent for treatment greater than or equal to 12 months during the measurement period
Equals Initial Population
None
Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment
Not Applicable
Patient refused recommendation for a bone density evaluation after the start of ADT therapy
A higher score indicates better quality
In order to capture the practitioner's intent of androgen deprivation therapy (ADT) for a period of 12 months or greater, SNOMEDCT 456381000124102 which is Injection of leuprolide acetate for twelve month period (regime/therapy) is the correct code.
This eCQM is a patient-based measure.
This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM.
The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.
Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.
Patient refused the bone density evaluation at the time ordered or did not have it performed within 3 months after the start of ADT
This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.
Updated the eCQM version number.
Measure Section: eCQM Version Number
Source of Change: Standards Update
Updated copyright.
Measure Section: Copyright
Source of Change: Annual Update
Updated disclaimer.
Measure Section: Disclaimer
Added Androgen Deprivation Therapy for Urology Care Medication Order Start Dates definition, revised Androgen Deprivation Therapy for Urology Care Medication Active Start Dates definition and revised Androgen Deprivation Therapy Start Date definition, all referenced in the initial population and numerator, to account for addition of ordered medications to align with measure intent.
Measure Section: Initial Population
Source of Change: Measure Lead
Changed timing in the Androgen Deprivation Therapy Start Date definition from 'overlaps' the measurement period to 'before end of' the measurement period to meet measure intent.
Source of Change: Expert Work Group Review
Updated logic from 'on or before end of' prostate cancer prevalence period to 'during' prostate cancer prevalence period in the Androgen Deprivation Therapy Start Date definition as ADT must occur during the prostate cancer prevalence period, not before.
Added Androgen Deprivation Therapy for Urology Care Medication Order Start Dates definition and revised Androgen Deprivation Therapy Start Date definition, referenced in the initial population and numerator, to account for ordered medications to align with measure intent.
Measure Section: Numerator
Measure Section: Definitions
Added Androgen Deprivation Therapy for Urology Care Medication Order Start Dates definition and revised the Androgen Deprivation Therapy Start Date definition to include orders for medication.
Source of Change: Logic Review
Updated logic from 'starts on or before end' of prostate cancer prevalence period to 'during' prostate cancer prevalence period in the Androgen Deprivation Therapy Start Date definition as ADT must occur during the prostate cancer prevalence period, not before.
Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with the CQL Style Guide.
Measure Section: Multiple Sections
Updated the version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-6.2.000). Updated the 'Inpatient Encounter' definition to include a 'day of' timing clarification. Added the following timing functions: Normalize Interval, Has Start, Has End, Latest, Latest Of, Earliest, and Earliest Of. Please see individual measure details for application of specific timing functions.
Added new NormalizeInterval function to timing attributes to decrease implementation burden due to variable use of timing attributes for select QDM data types. The NormalizeInterval function was applied, where applicable, for the following data elements: Assessment, Performed; Device, Applied; Diagnostic Study, Performed; Intervention, Performed; Laboratory Test, Performed; Medication, Administered; Medication, Dispensed; Physical Exam, Performed; Procedure, Performed; Substance, Administered.
The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.
Value set Androgen deprivation therapy for Urology Care (2.16.840.1.113762.1.4.1151.48): Added 1 RxNorm code (314008) based on terminology update. Deleted 1 RxNorm code (571914) based on terminology update.
Measure Section: Terminology